Optegra first to use cataract laser in UK

Article

Optegra is the first to offer the LensAR cataract laser in its London eye hospital.

Optegra is the first to offer the LensAR cataract laser in its London eye hospital.

The LensAR system, launched by Topcon, will be operated by a team of consultant ophthalmic surgeons led by Director of Laser Cataract Surgery for Optegra, Sundeep Kheterpal.

CE-marked and user-friendly, the system has a servo-controlled docking system that features a 'no corneal touch' liquid patient interface. This reportedly improves patient comfort and avoids compression and distortion to the cornea.

Mr Kheterpal commented, "Optegra has invested in this latest equipment to ensure we continue to offer the best possible service to our patients. Suitable for treatment of patients having both cataract surgery and Clarivu permanent lens replacement, the LensAR system has been designed to enhance the accuracy of surgery."

"The advantages of LensAR include full 3D custom imaging (CSI) of each individual eye, both posterior and anterior, to ensure precision and reproducibility. This enables the laser technology to perform laser incisions, which are more consistent and precise than ever before. The imaging is fully automated and there are multiple screens for ultimate accuracy and detail, leading to a most highly-informed diagnosis and accurate surgical procedure."

Optometrists and physicians wishing to offer their patients this cataract laser treatment are welcome to contact Hospital Manager Farzam Jafari, Optegra Eye Hospital, London, on +44 800 358 0825.

Related Videos
A screenshot of Dr Filomena Ribeiro, president of the ESCRS
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.